Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CANAGLIFLOZIN Cause Atrioventricular block complete? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Atrioventricular block complete have been filed in association with CANAGLIFLOZIN (INVOKANA). This represents 0.0% of all adverse event reports for CANAGLIFLOZIN.

8
Reports of Atrioventricular block complete with CANAGLIFLOZIN
0.0%
of all CANAGLIFLOZIN reports
1
Deaths
8
Hospitalizations

How Dangerous Is Atrioventricular block complete From CANAGLIFLOZIN?

Of the 8 reports, 1 (12.5%) resulted in death, 8 (100.0%) required hospitalization.

Is Atrioventricular block complete Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CANAGLIFLOZIN. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does CANAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,413) Toe amputation (2,193) Osteomyelitis (2,146) Acute kidney injury (1,853) Fungal infection (1,385) Gangrene (1,081) Weight decreased (1,014) Cellulitis (1,007) Urinary tract infection (920) Diabetic foot infection (832)

What Other Drugs Cause Atrioventricular block complete?

BISOPROLOL (261) VERAPAMIL (210) METOPROLOL (209) AMLODIPINE (149) DILTIAZEM (141) RITUXIMAB (139) AMIODARONE (138) LACOSAMIDE (130) ATORVASTATIN (127) PEMBROLIZUMAB (122)

Which CANAGLIFLOZIN Alternatives Have Lower Atrioventricular block complete Risk?

CANAGLIFLOZIN vs CANAGLIFLOZIN\METFORMIN CANAGLIFLOZIN vs CANAKINUMAB CANAGLIFLOZIN vs CANDESARTAN CANAGLIFLOZIN vs CANDESARTAN CILEXETIL CANAGLIFLOZIN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE

Related Pages

CANAGLIFLOZIN Full Profile All Atrioventricular block complete Reports All Drugs Causing Atrioventricular block complete CANAGLIFLOZIN Demographics